back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-10-07 20:10 Tx date 2019-05-27 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-10-07 20:06 Tx date 2024-09-26 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+1,000,000 vol |
1,000,000 | |
| Filed 2024-10-07 18:07 Tx date 2019-05-27 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-10-07 15:38 Tx date 2019-05-27 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-10-07 15:38 Tx date 2019-05-27 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-12-18 13:50 Tx date 2023-12-15 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$37,500
+50,000 vol $0.75 each |
1,050,000 | |
| Filed 2022-12-09 09:52 Tx date 2022-12-08 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
900,000 | |
| Filed 2022-08-02 11:39 Tx date 2022-08-02 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$11,000
+25,000 vol $0.44 each |
1,000,000 | |
| Filed 2022-04-06 12:15 Tx date 2022-03-31 |
$TTI
Thiogenesis Therapeutics, Corp. (formerly Rozdil Capital Corporation) |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$262,500
+750,000 vol $0.35 each |
750,000 | |
| Filed 2022-03-31 10:09 Tx date 2022-03-22 |
$ROZP
Rozdil Capital Corporation |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$12,500
+125,000 vol $0.10 each |
975,000 | |
| Filed 2022-03-31 10:06 Tx date 2022-03-22 |
$ROZP
Rozdil Capital Corporation |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-12,500
-125,000 vol $0.10 each |
0 | |
| Filed 2019-07-18 15:41 Tx date 2019-07-16 |
$ROZP
Rozdil Capital Corporation |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
125,000 | |
| Filed 2019-07-18 14:15 Tx date 2019-05-27 |
$ROZP
Rozdil Capital Corporation |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-06-11 10:30 Tx date 2019-05-27 |
$
Rozdil Capital Corporation |
Riggins, Brook
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
850,000 |